Anchoring dipalmitoyl phosphoethanolamine to nanoparticles boosts cellular uptake and fluorine-19 magnetic resonance signal

Scientific Reports

Volumn 5, Issue , 2015, Pages 8427-

  Waiczies, Sonia ^a   Lepore, Stefano ^a   Sydow, Karl ^b   Drechsler, Susanne ^a   Ku, Min Chi ^a   Martin, Conrad ^a   Lorenz, Dorothea ^b   Schütz, Irene ^b   Reimann, Henning M ^a   Purfürst, Bettina ^a   Dieringer, Matthias A ^a,d   Waiczies, Helmar ^c   Dathe, Margitta ^b   Pohlmann, Andreas ^a   Niendorf, Thoralf ^a  

^a MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

^b LEIBNIZ INSTITUT FÜR MOLEKULARE PHARMAKOLOGIE   (Germany)

^c MRI TOOLS GMBH   (Germany)

^d Experimental and Clinical Research Center   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

1,2-DIPALMITOYL-3-PHOSPHATIDYLETHANOLAMINE; FLUORINE; NANOPARTICLE; PHOSPHATIDYLETHANOLAMINE;

ANIMAL; CELL MOTION; CELL TRACKING; CHEMISTRY; DENDRITIC CELL; IMMUNOLOGY; INTRACELLULAR SPACE; METABOLISM; MOUSE; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PROCEDURES; PROTON NUCLEAR MAGNETIC RESONANCE; TRANSPORT AT THE CELLULAR LEVEL; ULTRASTRUCTURE;

ANIMALS; BIOLOGICAL TRANSPORT; CELL MOVEMENT; CELL TRACKING; DENDRITIC CELLS; FLUORINE; INTRACELLULAR SPACE; MAGNETIC RESONANCE SPECTROSCOPY; MICE; NANOPARTICLES; PHOSPHATIDYLETHANOLAMINES; PROTON MAGNETIC RESONANCE SPECTROSCOPY;

EID: 84923021226     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep08427     Document Type: Article

References (69)

1. Dekaban, G. A. et al. Tracking and evaluation of dendritic cell migration by cellular magnetic resonance imaging. Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology 5, 469-483, doi:10.1002/wnan.1227 (2013).
2. Palucka, K. & Banchereau, J. Dendritic-cell-based therapeutic cancer vaccines. Immunity 39, 38-48, doi:10.1016/j.immuni.2013.07.004 (2013).
3. Ahrens, E. T., Flores, R., Xu, H. & Morel, P. A. In vivo imaging platform for tracking immunotherapeutic cells. Nat.Biotechnol. 23, 983-987 (2005).
4. Srinivas, M.,Heerschap, A., Ahrens, E. T., Figdor, C. G. & de Vries, I. J. (19)F MRI for quantitative in vivo cell tracking. Trends Biotechnol. 28, 363-370 (2010).
5. Waiczies, H. et al. Perfluorocarbon particle size influences magnetic resonance signal and immunological properties of dendritic cells. PLoS One 6, e21981 (2011).
6. Waiczies, H. et al. Monitoring Dendritic Cell Migration using 19F/1H Magnetic Resonance Imaging. J Vis Exp. doi: 10.3791/50251 (2013).
7. de Vries, I. J. et al. Magnetic resonance tracking of dendritic cells in melanoma patients for monitoring of cellular therapy. Nat.Biotechnol. 23, 1407-1413 (2005).
8. Brooks, R. A., Brunetti, A., Alger, J. R. & Di Chiro, G. On the origin of paramagnetic inhomogeneity effects in blood. Magn Reson.Med. 12, 241-248 (1989).
9. Lee, N., Inouye, M. & Lauterbur, P. C. 19F- and 13C-NMR studies of a specifically labelled lipoprotein in the Eschericia coli membrane. Biochemical and biophysical research communications 78, 1211-1218 (1977).
10. Holland, G. N., Bottomley, P. A. & Hinshaw, W. S. F-19 Magnetic-Resonance Imaging. Journal of Magnetic Resonance 28, 133-136 (1977).
11. Liu, M. S. & Long, D. M. Perfluoroctylbromide as a diagnostic contrast medium in gastroenterography. Radiology 122, 71-76 (1977).
12. Waiczies, H. et al. Visualizing brain inflammation with a shingled-leg radiofrequency head probe for 19F/1H MRI. Sci.Rep. 3, 1280 (2013).
13. Bé gué, J.-P. & Bonnet-Delpon, D. Bioorganic and medicinal chemistry of fluorine. (John Wiley & Sons, 2008).
14. Gerebtzoff, G., Li-Blatter, X., Fischer, H., Frentzel, A. & Seelig, A. Halogenation of drugs enhances membrane binding and permeation. Chembiochem : a European journal of chemical biology 5, 676-684, doi:10.1002/cbic.200400017 (2004).
15. Smart, B. E. Fluorine substituent effects (on bioactivity). J Fluorine Chem 109, 3-11, doi:Doi 10.1016/S0022-1139(01)00375-X (2001).
16. Banchereau, J. & Palucka, A. K. Dendritic cells as therapeutic vaccines against cancer. Nature Reviews Immunology 5, 296-306 (2005).
17. Ahrens, E. T., Helfer, B. M., O'Hanlon, C. F. & Schirda, C. Clinical cell therapy imaging using a perfluorocarbon tracer and fluorine-19 MRI. Magnetic Resonance in Medicine, doi:doi: 10.1002/mrm.25454 (2014).
18. Balasubramanian, K. & Schroit, A. J. Aminophospholipid asymmetry: Amatter of life and death. Annu Rev Physiol 65, 701-734, doi:DOI 10.1146/annurev.physiol.65.092101.142459 (2003).
19. Smaby, J. M., Brockman, H. L.& Brown, R. E. Cholesterols Interfacial Interactions with Sphingomyelins and Phosphatidylcholines - Hydrocarbon Chain Structure Determines the Magnitude of Condensation. Biochemistry-Us 33, 9135-9142, doi:Doi 10.1021/Bi00197a016 (1994).
20. Sprong, H., van der Sluijs, P. & van Meer, G. How proteins move lipids and lipids move proteins. Nat Rev Mol Cell Biol 2, 504-513 (2001).
21. Felgner, J. H. et al. Enhanced gene delivery and mechanism studies with a novel series of cationic lipid formulations. Journal of Biological Chemistry 269, 2550-2561 (1994).
22. Hyvönen, Z. et al. Dioleoyl phosphatidylethanolamine and PEG-lipid conjugates modify DNA delivery mediated by 1, 4-dihydropyridine amphiphiles. Journal of Controlled Release 99, 177-190 (2004).
23. Antonelli, A. et al . Improved cellular uptake of functionalized single-walled carbon nanotubes. Nanotechnology 21, 425101 (2010).
24. Caliceti, P. & Veronese, F. M. Pharmacokinetic and biodistribution properties of poly(ethylene glycol)-protein conjugates. Advanced drug delivery reviews 55, 1261-1277 (2003).
25. Allen, T. M., Hansen, C., Martin, F., Redemann, C. & Yau-Young, A. Liposomes containing synthetic lipid derivatives of poly(ethylene glycol) show prolonged circulation half-lives in vivo. Biochimica et biophysica acta 1066, 29-36 (1991).
26. Fang, C. et al. In vivo tumor targeting of tumor necrosis factor-α-loaded stealth nanoparticles: Effect of MePEG molecular weight and particle size. European Journal of Pharmaceutical Sciences 27, 27-36, doi:http://dx.doi.org/10.1016/j.ejps.2005.08.002 (2006).
27. Zachowski, A. Phospholipids in animal eukaryotic membranes: transverse asymmetry and movement. The Biochemical journal 294 (Pt1), 1-14 (1993).
28. Virtanen, J. A., Cheng, K. H. & Somerharju, P. Phospholipid composition of the mammalian red cell membrane can be rationalized by a superlattice model. Proceedings of the National Academy of Sciences of the United States of America 95, 4964-4969 (1998).
29. Emoto, K. et al. Redistribution of phosphatidylethanolamine at the cleavage furrow of dividing cells during cytokinesis. Proceedings of the National Academy of Sciences 93, 12867-12872 (1996).
30. Riekhof, W. R. & Voelker, D. R. Uptake and utilization of lysophosphatidylethanolamine by Saccharomyces cerevisiae. Journal of Biological Chemistry 281, 36588-36596 (2006).
31. Muller, K., Pomorski, T., Muller, P., Zachowski, A. & Herrmann, A. Proteindependent translocation of aminophospholipids and asymmetric transbilayer distribution of phospholipids in the plasma membrane of ram sperm cells. Biochemistry-Us 33, 9968-9974 (1994).
32. Laulagnier, K. et al. Mast cell-and dendritic cell-derived exosomes display a specific lipid composition and an unusual membrane organization. Biochem. J 380, 161-171 (2004).
33. Steinman, R.M., Mellman, I. S., Muller, W. A. & Cohn, Z. A. Endocytosis and the recycling of plasma membrane. The Journal of cell biology 96, 1-27 (1983).
34. Steinman, R.M., Brodie, S. E.&Cohn, Z. A. Membrane flow during pinocytosis. A stereologic analysis. The Journal of cell biology 68, 665-687 (1976).
35. Wang, X. & Quinn, P. J. Cubic phase is induced by cholesterol in the dispersion of 1-palmitoyl-2-oleoyl-phosphatidylethanolamine. Biochimica et Biophysica Acta (BBA)-Biomembranes 1564, 66-72 (2002).
36. Arouri, A., Dathe, M. & Blume, A. Peptide induced demixing in PG/PE lipid mixtures: a mechanism for the specificity of antimicrobial peptides towards bacterial membranes? Biochimica et Biophysica Acta (BBA)-Biomembranes 1788, 650-659 (2009).
37. Fontana, G., Licciardi, M., Mansueto, S., Schillaci, D. & Giammona, G. Amoxicillin-loaded polyethylcyanoacrylate nanoparticles: Influence of PEG coating on the particle size, drug release rate and phagocytic uptake. Biomaterials 22, 2857-2865, doi:http://dx.doi.org/10.1016/S0142-9612(01)00030-8 (2001).
38. Klibanov, A. L., Maruyama, K., Torchilin, V. P. & Huang, L. Amphipathic polyethyleneglycols effectively prolong the circulation time of liposomes. FEBS Lett 268, 235-237 (1990).
39. Klibanov, A. L., Maruyama, K., Beckerleg, A. M., Torchilin, V. P. & Huang, L. Activity of amphipathic poly(ethylene glycol) 5000 to prolong the circulation time of liposomes depends on the liposome size and is unfavorable for immunoliposome binding to target. Biochimica et Biophysica Acta (BBA) -Biomembranes 1062, 142-148, doi:http://dx.doi.org/10.1016/0005-2736(91)90385-L (1991).
40. Mori, A., Klibanov, A. L., Torchilin, V. P. & Huang, L. Influence of the steric barrier activity of amphipathic poly(ethyleneglycol) and ganglioside GM1 on the circulation time of liposomes and on the target binding of immunoliposomes in vivo. FEBS Lett 284, 263-266, doi:http://dx.doi.org/10.1016/0014-5793(91)80699-4 (1991).
41. Koren, E., Apte, A., Sawant, R. R., Grunwald, J. & Torchilin, V. P. Cell-penetrating TAT peptide in drug delivery systems: Proteolytic stability requirements. Drug delivery 18, 377-384, doi:10.3109/10717544.2011.567310 (2011).
42. Lukyanov, A., Gao, Z., Mazzola, L. & Torchilin, V. Polyethylene Glycol-Diacyllipid Micelles Demonstrate Increased Accumulation in Subcutaneous Tumors in Mice. Pharm Res 19, 1424-1429, doi:10.1023/a:1020488012264 (2002).
43. Torchilin, V. P. Micellar Nanocarriers: Pharmaceutical Perspectives. Pharm Res 24, 1-16, doi:10.1007/s11095-006-9132-0 (2007).
44. Kale, A. A. & Torchilin, V. P. "Smart" Drug Carriers: PEGylated TATp-Modified pH-Sensitive Liposomes. Journal of Liposome Research 17, 197-203, doi:10.1080/08982100701525035 (2007).
45. Sydow, K., Torchilin, V. P. & Dathe, M. Lipopeptide-modified PEG-PE-based pharmaceutical nanocarriers for enhanced uptake in blood-brain barrier cells and improved cytotoxicity against glioma cells. European Journal of Lipid Science and Technology 116, 1174-1183, doi:10.1002/ejlt.201300373 (2014).
46. Sauer, I., Dunay, I. R.,Weisgraber, K., Bienert, M. & Dathe, M. An apolipoprotein E-derived peptide mediates uptake of sterically stabilized liposomes into brain capillary endothelial cells. Biochemistry-Us 44, 2021-2029 (2005).
47. Felgner, J. H. et al. Enhanced gene delivery and mechanism studies with a novel series of cationic lipid formulations. Journal of Biological Chemistry 269, 2550-2561 (1994).
48. Sydow, K., Torchilin, V. P. & Dathe, M. Lipopeptide-modified PEG-PE-based pharmaceutical nanocarriers for enhanced uptake in blood-brain barrier cells and improved cytotoxicity against glioma cells. European Journal of Lipid Science and Technology 116, 1174-1183, doi:10.1002/ejlt.201300373 (2014).
49. Ramezani, M., Khoshhamdam, M., Dehshahri, A. & Malaekeh-Nikouei, B. The influence of size, lipid composition and bilayer fluidity of cationic liposomes on the transfection efficiency of nanolipoplexes. Colloid Surface B 72, 1-5, doi:DOI 10.1016/j.colsurfb.2009.03.018 (2009).
50. van Dommelen, S. M. et al. Microvesicles and exosomes: Opportunities for cellderived membrane vesicles in drug delivery. Journal of Controlled Release 161, 635-644, doi:DOI 10.1016/j.jconrel.2011.11.021 (2012).
51. Larson, M. C., Woodliff, J. E., Hillery, C. A., Kearl, T. J. & Zhao, M. Phosphatidylethanolamine is externalized at the surface of microparticles. Biochimica et biophysica acta 1821, 1501-1507, doi:10.1016/j.bbalip.2012.08.017 (2012).
52. Wolf, P. The nature and significance of platelet products in human plasma. British journal of haematology 13, 269-288 (1967).
53. Roseblade, A. et al. Cell-derived microparticles: new targets in the therapeutic management of disease. Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques 16, 238-253 (2013).
54. Hargett, L. A. & Bauer, N. N. On the origin of microparticles: From "platelet dust" to mediators of intercellular communication. Pulmonary circulation 3, 329-340, doi:10.4103/2045-8932.114760 (2013).
55. Deregibus, M. C. et al. Endothelial progenitor cell derived microvesicles activate an angiogenic program in endothelial cells by a horizontal transfer of mRNA. Blood 110, 2440-2448, doi:10.1182/blood-2007-03-078709 (2007).
56. Saulnier, P., Foussard, F., Boury, F. & Proust, J. Structural properties of asymmetric mixed-chain phosphatidylethanolamine films. Journal of colloid and interface science 218, 40-46 (1999).
57. Malcharek, S., Hinz, A., Hilterhaus, L. & Galla, H.-J. Multilayer structures in lipid monolayer films containing surfactant protein C: effects of cholesterol and POPE. Biophysical Journal 88, 2638-2649 (2005).
58. Epand, R. M. & Bottega, R. Determination of the phase behaviour of phosphatidylethanolamine admixed with other lipids and the effects of calcium chloride: implications for protein kinase C regulation. Biochimica et Biophysica Acta (BBA) - Biomembranes 944, 144-154, doi:http://dx.doi.org/10.1016/0005-2736(88)90427-0 (1988).
59. Crowley, J. J., Treistman, S. N. & Dopico, A. M. Distinct Structural Features of Phospholipids Differentially Determine Ethanol Sensitivity and Basal Function of BK Channels. Mol Pharmacol 68, 4-10, doi:10.1124/mol.105.012971 (2005).
60. Gratton, S. E. A. et al. The effect of particle design on cellular internalization pathways. Proceedings of the National Academy of Sciences 105, 11613-11618, doi:10.1073/pnas.0801763105 (2008).
61. Champion, J. A. & Mitragotri, S. Role of target geometry in phagocytosis. Proceedings of the National Academy of Sciences of the United States of America 103, 4930-4934, doi:10.1073/pnas.0600997103 (2006).
62. Yan, L.-T. & Xie, X.-M. Computational modeling and simulation of nanoparticle self-assembly in polymeric systems: Structures, properties and external field effects. Progress in Polymer Science 38, 369-405 (2013).
63. van der Veen, R. M., Kwon, O.-H., Tissot, A., Hauser, A. & Zewail, A. H. Singlenanoparticle phase transitions visualized by four-dimensional electron microscopy. Nature chemistry 5, 395-402 (2013).
64. Adrian, M., Dubochet, J., Lepault, J. & McDowall, A. W. Cryo-electron microscopy of viruses. Nature 308, 32-36 (1984).
65. Bendix, I. et al. MAPK3 deficiency drives autoimmunity via DCarming. European journal of immunology 40, 1486-1495, doi:10.1002/eji.200939930 (2010).
66. Wiggins, H. & Rappoport, J. An agarose spot assay for chemotactic invasion. BioTechniques 48, 121-124, doi:10.2144/000113353 (2010).
67. Schindelin, J. et al. Fiji: an open-source platform for biological-image analysis. Nat Methods 9, 676-682, doi:Doi 10.1038/Nmeth.2019 (2012).
68. Gruetter, R. Automatic, localized in vivo adjustment of all first- and second-order shim coils. Magnetic resonance in medicine : official journal of the Society of Magnetic Resonance in Medicine/Society of Magnetic Resonance in Medicine 29, 804-811 (1993).
69. Economopoulos, V., Noad, J. C., Krishnamoorthy, S., Rutt, B. K. & Foster, P. J. Comparing the MRI appearance of the lymph nodes and spleen in wild-type and immuno-deficient mouse strains. PLoS One 6, e27508, doi:10.1371/journal.pone.0027508 (2011).